DOC on XNYS, Real Estate, Healthpeak Properties, Inc., job postings
Measures activity, not value. Not investment advice.
Quarterly revenue rose 16% to $821M and shares gained 11% in 12 months.
GoodTrailing 12-month revenue up 9.4% to $3.1B
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $820.9M, net income $17.3M.
31 Dec 2021RevenueNet incomeNet losstallest bar $820.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$820.9M
$17.3M
30 Jun 2026
$771.6M
$52.8M
31 Mar 2026
$753.0M
$193.6M
31 Dec 2025
$719.4M
$114.0M
30 Sep 2025
$705.9M
-$117.1M
30 Jun 2025
$694.3M
$31.7M
31 Mar 2025
$702.9M
$42.8M
31 Dec 2024
$698.0M
$4.5M
30 Sep 2024
$700.4M
$85.9M
30 Jun 2024
$695.5M
$146.0M
31 Mar 2024
$606.6M
$6.7M
31 Dec 2023
$553.7M
$70.9M
30 Sep 2023
$556.2M
$64.2M
30 Jun 2023
$545.4M
$51.9M
31 Mar 2023
$525.7M
$119.0M
31 Dec 2022
$524.5M
$6.5M
30 Sep 2022
$520.4M
$354.0M
30 Jun 2022
$517.9M
$68.3M
31 Mar 2022
$498.4M
$71.6M
31 Dec 2021
$483.2M
$28.8M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$3.1B
$2.8B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+9.4%
+5.2%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$377.7M
-$38.1M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$0.54
-$0.06
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
60.1%
68.4%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
37.9%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
12.3%
-1.4%
14.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
4.9%
4.4%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$514.3M
$91.0M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
–
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
–
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
1.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$11.41
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
35.1
24.5
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
4.3
4.5
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
9.8
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
1.7
1.1
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
6.3%
5.1%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$127K
bought $0, sold $127K
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+2.3%
756 13F filers vs 739
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
94%
649.3M shares held by 13F filers (30 Sep 2026) of 689.5M outstanding (30 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
3.3%
22.9M shares sold short (30 Oct 2026) of 689.5M outstanding (30 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.0
22.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+5.2%
21.7M shares sold short in the report before, 22.9M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
61%
61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 53%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+16%
$820.9M vs $705.9M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$60K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
23
23 articles in the last 7 days; its usual week has 4 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
5.8×
23 articles in the last 7 days; its usual week has 4.
Unusual now sharp changes in the last 90 days, compared with its own past
Revenue $268.3M, 1.8× a year earlier
Price $19.24 on 20 Nov 2026, +11% over 12 months (12-month range $15.78 to $22.82)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $341K in the last 12 months (the 12 months before: $1.1M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).Revenue per quarter. Revenue $820.9M in the latest quarter, +16% on a year earlier.Institutional holders (13F filers). 756 13F filers reported holding it in the latest 13F quarter, +6.6% on a year earlier.Lobbying spend. Lobbying spend: $60K published in the last 12 months, -69% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: capital spending per quarter, federal obligations, workers in warn layoff notices.
Reported lobbying spend: $60K in Q3 2026, $60K in Q3 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Jan 2018
New
Marshall Brachmanfor Healthpeak Properties, Inc. Fka Physicians Realty Trust
monitor for tax issues affecting real estate investment trusts general health care policy affecting hospitals and physician practicesTaxation, Health issues
Two or more unrelated kinds of records unusual within 30 days
29 Apr 2025confirmed
Confirmed across sources Insiders and Short interest and volume
Healthpeak Properties(DOC): had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year, while it had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 27 days.
Short interest and volume: Short interest spike, became public on 26 Mar 2025
Insiders: Clustered insider buying, became public on 29 Apr 2025
The 14 Mar 2025 report against the 24 reports before it.
this reportearliernormal: 11.0MSee the evidence (2 changes)
Short interest and volume: Short interest spike became public on 26 Mar 2025
Healthpeak Properties had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.
This period
15.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
11.0M
Typical spread (median absolute deviation)
713K
How far from its usual level
+4.4
Same report last year
9.7M
History used
2,632 days
the 14 Mar 2025 report24 earlier reportsnormal: 11.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
7 May 2019confirmed
Confirmed across sources Filings + Financials and Short interest and volume
Healthpeak Properties(DOC): had 9.0M shares sold short in the 29 Mar 2019 report, 2.2× the same report last year, while it reported revenue of $126.7M for the quarter ended 31 Mar 2019, 74% below the same quarter last year. Two unrelated kinds of activity within 28 days.
Short interest and volume: Short interest spike, became public on 10 Apr 2019
Short interest and volume: Short interest spike, became public on 26 Apr 2019
Financials: Quarterly revenue change, became public on 7 May 2019
Short interest and volume: Short interest spike, became public on 10 May 2019
The 29 Mar 2019 report against the 24 reports before it.
this reportearliernormal: 4.8MSee the evidence (4 changes)
Short interest and volume: Short interest spike became public on 10 Apr 2019
Healthpeak Properties had 9.0M shares sold short in the 29 Mar 2019 report, 2.2× the same report last year.
This period
9.0M (the 29 Mar 2019 report)
Normal report (median of 24 earlier)
4.8M
Typical spread (median absolute deviation)
569K
How far from its usual level
+4.9
Same report last year
4.2M
History used
455 days
the 29 Mar 2019 report24 earlier reportsnormal: 4.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Apr 2019
Healthpeak Properties had 8.6M shares sold short in the 15 Apr 2019 report, 1.9× the same report last year.
This period
8.6M (the 15 Apr 2019 report)
Normal report (median of 24 earlier)
4.9M
Typical spread (median absolute deviation)
618K
How far from its usual level
+4.0
Same report last year
4.5M
History used
472 days
the 15 Apr 2019 report24 earlier reportsnormal: 4.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly revenue change became public on 7 May 2019
Healthpeak Properties reported revenue of $126.7M for the quarter ended 31 Mar 2019, 74% below the same quarter last year.
This period
$126.7M (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
$457.5M
Typical spread (median absolute deviation)
$13.1M
How far from its usual level
-7.2
Same quarter last year
$479.2M
History used
3,926 days
the quarter ended 31 Mar 20198 earlier quartersnormal: $457.5M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Short interest and volume: Short interest spike became public on 10 May 2019
Healthpeak Properties had 8.5M shares sold short in the 30 Apr 2019 report, 1.7× the same report last year.
This period
8.5M (the 30 Apr 2019 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
565K
How far from its usual level
+4.0
Same report last year
4.9M
History used
487 days
the 30 Apr 2019 report24 earlier reportsnormal: 5.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
5 Nov 2026Financials change
reported revenue of $268.3M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year.
Same quarter last year: $150.5M; its normal quarter is $149.7M.
See the evidence
This period
$268.3M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$149.7M
Typical spread (median absolute deviation)
$4.9M
How far from its usual level
+7.9
Same quarter last year
$150.5M
History used
3,835 days
the quarter ended 30 Sep 20268 earlier quartersnormal: $149.7M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $216.5M for the quarter ended 30 Jun 2026, 1.5× the same quarter last year.
Same quarter last year: $148.9M; its normal quarter is $148.9M.
See the evidence
This period
$216.5M (the quarter ended 30 Jun 2026)
Normal quarter (median of 8 earlier)
$148.9M
Typical spread (median absolute deviation)
$4.5M
How far from its usual level
+4.5
Same quarter last year
$148.9M
History used
3,743 days
the quarter ended 30 Jun 20268 earlier quartersnormal: $148.9M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $200.3M for the quarter ended 31 Mar 2026, 1.3× the same quarter last year.
Same quarter last year: $148.9M; its normal quarter is $147.4M.
See the evidence
This period
$200.3M (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
$147.4M
Typical spread (median absolute deviation)
$3.8M
How far from its usual level
+3.6
Same quarter last year
$148.9M
History used
3,652 days
the quarter ended 31 Mar 20268 earlier quartersnormal: $147.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 31.2M shares sold short in the 13 Feb 2026 report, 2.3× the same report last year.
Same report last year: 13.8M; its normal report is 17.5M.
See the evidence
This period
31.2M (the 13 Feb 2026 report)
Normal report (median of 24 earlier)
17.5M
Typical spread (median absolute deviation)
2.4M
How far from its usual level
+3.8
Same report last year
13.8M
History used
2,968 days
the 13 Feb 2026 report24 earlier reportsnormal: 17.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 27.3M shares sold short in the 30 Jan 2026 report, 2.2× the same report last year.
Same report last year: 12.3M; its normal report is 16.8M.
See the evidence
This period
27.3M (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
16.8M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+3.6
Same report last year
12.3M
History used
2,954 days
the 30 Jan 2026 report24 earlier reportsnormal: 16.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 20.7M shares sold short in the 13 Jun 2025 report, 1.8× the same report last year.
Same report last year: 11.6M; its normal report is 11.2M.
See the evidence
This period
20.7M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
11.2M
Typical spread (median absolute deviation)
1.6M
How far from its usual level
+4.1
Same report last year
11.6M
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 11.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year, while it had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 27 days.
See the evidence (2 changes)
Short interest and volume: Short interest spike became public on 26 Mar 2025
Healthpeak Properties had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.
This period
15.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
11.0M
Typical spread (median absolute deviation)
713K
How far from its usual level
+4.4
Same report last year
9.7M
History used
2,632 days
the 14 Mar 2025 report24 earlier reportsnormal: 11.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
29 Apr 2025Insiders change
had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings).
Who bought: Shelley-Kessler Pamela, Lewis Sara Grootwassink, Thomas John T, Sandstrom Katherine M and 1 more.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.
Same report last year: 9.7M; its normal report is 11.0M.
See the evidence
This period
15.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
11.0M
Typical spread (median absolute deviation)
713K
How far from its usual level
+4.4
Same report last year
9.7M
History used
2,632 days
the 14 Mar 2025 report24 earlier reportsnormal: 11.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 15.5M shares sold short in the 28 Feb 2025 report, 2.9× the same report last year.
Same report last year: 5.4M; its normal report is 10.9M.
See the evidence
This period
15.5M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
10.9M
Typical spread (median absolute deviation)
652K
How far from its usual level
+4.3
Same report last year
5.4M
History used
2,618 days
the 28 Feb 2025 report24 earlier reportsnormal: 10.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 118 13F filers open a new position in the quarter ended 31 Mar 2024, 2.6× the same quarter last year.
Same quarter last year: 45; its normal quarter is 57.
See the evidence
This period
118 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
57
Typical spread (median absolute deviation)
8
How far from its usual level
+5.1
Same quarter last year
45
History used
1,644 days
the quarter ended 31 Mar 20248 earlier quartersnormal: 57
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Showing the newest 40 of 105 entries; narrow the window or the kind of data to see older ones.
Not listed: 181 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it